DANIEL G WELCH Insider Trading $AVXS AveXis, Inc.
Get free email notifications about insider trading for DANIEL G WELCH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL G WELCH. DANIEL G WELCH is CEO and President in INTERMUNE INC ($ITMN) and Chairman, CEO and President in INTERMUNE INC ($ITMN) and President & CEO in INTERMUNE INC ($ITMN) and President and CEO in INTERMUNE INC ($ITMN) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in HYPERION THERAPEUTICS INC ($HPTX) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in AveXis, Inc. ($AVXS) and Director in Nuvation Bio Inc. ($PANA).
DANIEL G WELCH in AveXis, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL G WELCH: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 15 2018
$AVXS Market Capitalization: $1.59B
$AVXS Previous Close: $58.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DANIEL G WELCH in AveXis, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVXS, HPTX, ICPT, ITMN, NUVB, SGEN, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | D | 133.80 | 2,905 | 388,689 | 0 | |
| May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | D | 69.25 | 2,454 | 169,940 | 0 | |
| May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | D | 20.00 | 35,552 | 711,040 | 0 | |
| May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Buy | D | 0.00 | 1,106 | 0 | 0 | -1,106 to 0 (-100.00 %) |
| Mar 30 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
| Mar 30 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
| Jun 01 2017 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | A | 69.25 | 2,454 | 169,940 | 2,454 | |
| Feb 12 2016 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | A | 20.00 | 8,385 | 167,700 | 8,385 | |
| Feb 12 2016 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | A | 20.00 | 27,167 | 543,340 | 27,167 |
Page: 1